Ligand profile
THU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4939 — cytidine deaminase
Identifiers
Database identifiers and provenance.
- Ligand ID
THU- PDB
1jtk- UniProt (similar protein)
P19079- Target protein
- VK055_4939
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 99.1
- −1 ≤ LogP ≤ 5 -1.60
- MW ≤ 500 Da 230.2
- LogP ≤ 5 -1.60
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 99.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1CN(C(=O)NC1=O)C2C[C@@H]([C@H](O2)CO)OC1CN(C(=O)NC1=O)C2C[C@@H]([C@H](O2)CO)O
InChI=1S/C9H14N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h5-6,8,12-13H,1-4H2,(H,10,14,15)/t5-,6+,8?/m0/s1InChI=1S/C9H14N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h5-6,8,12-13H,1-4H2,(H,10,14,15)/t5-,6+,8?/m0/s1
XMJRLEURHMTTRX-FWHJPCMOSA-NXMJRLEURHMTTRX-FWHJPCMOSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00383
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand THU →
- PDB RCSB structure 1jtk →
- UniProt UniProt P19079 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “THU”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4939.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 16
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).